ClinicalTrials.govpublic full text
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED
persistent corneal epithelial defect, pced, corneal defect, ped, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 804389
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.